ISRIB A15 is an enhanced analogue of the original ISRIB compound, designed with improved bioavailability and potency. It targets the eIF2B complex to inhibit the integrated stress response (ISR), potentially restoring cognitive function that has been impaired by stress, aging, or injury. A15 is specifically optimized for oral administration and research applications.